[go: up one dir, main page]

CH545296A - 4-amino-6,7,8-trimethoxyquinazolines - Google Patents

4-amino-6,7,8-trimethoxyquinazolines

Info

Publication number
CH545296A
CH545296A CH1519573A CH1519573A CH545296A CH 545296 A CH545296 A CH 545296A CH 1519573 A CH1519573 A CH 1519573A CH 1519573 A CH1519573 A CH 1519573A CH 545296 A CH545296 A CH 545296A
Authority
CH
Switzerland
Prior art keywords
formula
compounds
amino
formamide
known per
Prior art date
Application number
CH1519573A
Other languages
German (de)
Inventor
P Gabel Lloyd
Simpson William R J
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH545296A publication Critical patent/CH545296A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)

Abstract

4-Amino-6,7,8-trimethoxyquinazolines Cpds. of formula (I) (where Y, Y1 and Y2 are 1-3C alkoxy and R and R1 are H, 1-4C alkyl or a group -CH2(CH2)nONO2 (a), -CH2(CH2R2)nONO2 (b) or -CH2(CH2)zN CH2(CH2)zONO2 2 (c) in which R2 is -(CH2)mCH3 or -(CH2)yONO2, n is 1-6, m is 0-4 (7+n is not >6) y is 1-4 (n+y is not >7) and z is 1-4, at least one and not more than two nitrate groups being present and one of R and R1 being H or alkyl when the other is a group (b), or NRR1 is a residue and corr. cpds. in which -ONO2 residues are replaced by OH, have hypotensive and coronary dilating activity, some also have antiarrhythmic activity.

Description

  

  
 



   Die Erfindung betrifft ein Verfahren zur Herstellung von   6,7,84rialkoxychinazolin-4+3H) onen    der Formel I,
EMI1.1     
 worin Y, Y, und Y2 gleich oder verschieden sein können und jeweils   Aikoxy    mit 1-3 Kohlenstoffatomen bedeuten.



   Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass man Verbindungen der Formel II,
EMI1.2     
 worin Y,   Y1    und Y2 obige Bedeutung besitzen, mit Formamid kondensiert.



   Das Verfahren wird in an sich bekannter Weise durchgeführt, beispielsweise bei   Rückflusstemperatur    des Reaktionsgemisches.



   Die Verbindungen der Formel II sind bekannt oder in an sich bekannter Weise herstellbar. Zu ihnen kann man beispielsweise gelangen, indem man Verbindungen der   formel      III,   
EMI1.3     
 worin Y, Y, und Y2 obige Bedeutung haben, reduziert.



  Das Verfahren kann in herkömmlicher Weise durchgeführt werden, beispielsweise durch katalytische Hydrierung, z.B.   mittels    eines   'Palladium¯Kohle Katalysators.   



   Die Verbindungen der Formel III sind bekannt oder in an sich bekannter Weise herstellbar.



   Die Verbindungen der Formel I stellen Zwischenprodukte 'dar und können beispielsweise zur Herstellung wertvoller Pharmazeutika verwendet werden.



   Beispiel    6,7,8-Trimethoxychinazolin-4(3H)-on    a) 2-Amino-3,4,5-trimethoxymethylbenzoat
Ein Gemisch aus 39 g   2-Nitro-3,4,5-trimethoxymethyl-    benzoat, 100 ml Essigsäure und 2,5 g   5%    Palladium auf Kohle wird bei einer Temperatur von   600 C    25 Stunden mit Wasserstoff unter einem Druck von 3,5 kg/cm2 geschüttelt. Sodann wird abfiltriert und im Vakuum eingeengt. Der erhaltene Rückstand wird zwischen Methylenchlorid und einem   Überschuss    an Natriumcarbonat Lösung aufgeteilt. Die Methylenchlorid-Lösung wird getrocknet und im Vakuum eingeengt, und nach Destillation des hierbei erhaltenen Öls (105 C, 5 X 10-3 mm) gelangt man zu einem Öl von   2Amino-3,4,5-trimethoxyme-    thylbenzoat.



  b)   6,7,8-TrFrnethoxShiruzolin-4(3H)-on   
Eine Lösung von 24,2 g   2-Amino-3,4,5-Trimethoxy-    methylbenzoat in 80 ml 99%igem Formamid wird 1,25 Stunden zum   kückfluss    erhitzt. Man kühlt das Reaktionsgemisch ab, versetzt es mit 200 ml Eiswasser, filtriert den Feststoff ab, wäscht mit Wasser und trocknet, wobei man zum   6,7,8-Trimethoxychinazolin-4(3H)on    vom Smp. 2202220C gelangt.

 

      PATENTA0NSPRUCH   
Verfahren zur Herstellung von 6,7,8-Trialkoxychin   azolin-4(3H)onen    der Formel I,
EMI1.4     
 worin Y, Y1 und Y2 gleich oder verschieden sein können und jeweils   Alkoxy    mit 1-3 Kohlenstoffatomen bedeuten,   dadurch    gekennzeichnet, dass man Verbindungen der Formel II,
EMI1.5     
 worin Y, Y1 und   Y    obige Bedeutung besitzen, mit Formamid kondensiert.

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.



   



  
 



   The invention relates to a process for the preparation of 6,7,84rialkoxyquinazolin-4 + 3H) ones of the formula I,
EMI1.1
 where Y, Y and Y2 can be identical or different and each represent alkoxy having 1-3 carbon atoms.



   The inventive method is characterized in that compounds of the formula II,
EMI1.2
 wherein Y, Y1 and Y2 have the above meanings, condensed with formamide.



   The process is carried out in a manner known per se, for example at the reflux temperature of the reaction mixture.



   The compounds of the formula II are known or can be prepared in a manner known per se. You can get to them, for example, by using compounds of formula III,
EMI1.3
 where Y, Y, and Y2 have the above meanings, reduced.



  The process can be carried out in a conventional manner, for example by catalytic hydrogenation, e.g. using a palladium carbon catalyst.



   The compounds of the formula III are known or can be prepared in a manner known per se.



   The compounds of the formula I represent intermediates and can be used, for example, for the production of valuable pharmaceuticals.



   Example 6,7,8-Trimethoxyquinazolin-4 (3H) -one a) 2-Amino-3,4,5-trimethoxymethylbenzoate
A mixture of 39 g of 2-nitro-3,4,5-trimethoxymethyl benzoate, 100 ml of acetic acid and 2.5 g of 5% palladium on carbon is treated with hydrogen at a temperature of 600 ° C. for 25 hours under a pressure of 3.5 kg / cm2 shaken. It is then filtered off and concentrated in vacuo. The residue obtained is partitioned between methylene chloride and an excess of sodium carbonate solution. The methylene chloride solution is dried and concentrated in vacuo, and after distillation of the oil obtained in this way (105 ° C., 5 × 10-3 mm), an oil of 2-amino-3,4,5-trimethoxymethyl benzoate is obtained.



  b) 6,7,8-TrFrnethoxShiruzolin-4 (3H) -one
A solution of 24.2 g of 2-amino-3,4,5-trimethoxymethylbenzoate in 80 ml of 99% formamide is refluxed for 1.25 hours. The reaction mixture is cooled, 200 ml of ice water are added, the solid is filtered off, washed with water and dried, giving 6,7,8-trimethoxyquinazolin-4 (3H) one with a melting point of 2202220C.

 

      PATENT CLAIM
Process for the preparation of 6,7,8-trialkoxyquin azolin-4 (3H) ones of the formula I,
EMI1.4
 in which Y, Y1 and Y2 can be identical or different and are each alkoxy with 1-3 carbon atoms, characterized in that compounds of the formula II,
EMI1.5
 wherein Y, Y1 and Y have the above meanings, condensed with formamide.

** WARNING ** End of DESC field could overlap beginning of CLMS **.



   

 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Die Erfindung betrifft ein Verfahren zur Herstellung von 6,7,84rialkoxychinazolin-4+3H) onen der Formel I, EMI1.1 worin Y, Y, und Y2 gleich oder verschieden sein können und jeweils Aikoxy mit 1-3 Kohlenstoffatomen bedeuten. The invention relates to a process for the preparation of 6,7,84rialkoxyquinazolin-4 + 3H) ones of the formula I, EMI1.1 where Y, Y and Y2 can be identical or different and each represent alkoxy having 1-3 carbon atoms. Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass man Verbindungen der Formel II, EMI1.2 worin Y, Y1 und Y2 obige Bedeutung besitzen, mit Formamid kondensiert. The inventive method is characterized in that compounds of the formula II, EMI1.2 wherein Y, Y1 and Y2 have the above meanings, condensed with formamide. Das Verfahren wird in an sich bekannter Weise durchgeführt, beispielsweise bei Rückflusstemperatur des Reaktionsgemisches. The process is carried out in a manner known per se, for example at the reflux temperature of the reaction mixture. Die Verbindungen der Formel II sind bekannt oder in an sich bekannter Weise herstellbar. Zu ihnen kann man beispielsweise gelangen, indem man Verbindungen der formel III, EMI1.3 worin Y, Y, und Y2 obige Bedeutung haben, reduziert. The compounds of the formula II are known or can be prepared in a manner known per se. You can get to them, for example, by using compounds of formula III, EMI1.3 where Y, Y, and Y2 have the above meanings, reduced. Das Verfahren kann in herkömmlicher Weise durchgeführt werden, beispielsweise durch katalytische Hydrierung, z.B. mittels eines 'Palladium¯Kohle Katalysators. The process can be carried out in a conventional manner, for example by catalytic hydrogenation, e.g. using a palladium carbon catalyst. Die Verbindungen der Formel III sind bekannt oder in an sich bekannter Weise herstellbar. The compounds of the formula III are known or can be prepared in a manner known per se. Die Verbindungen der Formel I stellen Zwischenprodukte 'dar und können beispielsweise zur Herstellung wertvoller Pharmazeutika verwendet werden. The compounds of the formula I represent intermediates and can be used, for example, for the production of valuable pharmaceuticals. Beispiel 6,7,8-Trimethoxychinazolin-4(3H)-on a) 2-Amino-3,4,5-trimethoxymethylbenzoat Ein Gemisch aus 39 g 2-Nitro-3,4,5-trimethoxymethyl- benzoat, 100 ml Essigsäure und 2,5 g 5% Palladium auf Kohle wird bei einer Temperatur von 600 C 25 Stunden mit Wasserstoff unter einem Druck von 3,5 kg/cm2 geschüttelt. Sodann wird abfiltriert und im Vakuum eingeengt. Der erhaltene Rückstand wird zwischen Methylenchlorid und einem Überschuss an Natriumcarbonat Lösung aufgeteilt. Die Methylenchlorid-Lösung wird getrocknet und im Vakuum eingeengt, und nach Destillation des hierbei erhaltenen Öls (105 C, 5 X 10-3 mm) gelangt man zu einem Öl von 2Amino-3,4,5-trimethoxyme- thylbenzoat. Example 6,7,8-Trimethoxyquinazolin-4 (3H) -one a) 2-Amino-3,4,5-trimethoxymethylbenzoate A mixture of 39 g of 2-nitro-3,4,5-trimethoxymethyl benzoate, 100 ml of acetic acid and 2.5 g of 5% palladium on carbon is treated with hydrogen at a temperature of 600 ° C. for 25 hours under a pressure of 3.5 kg / cm2 shaken. It is then filtered off and concentrated in vacuo. The residue obtained is partitioned between methylene chloride and an excess of sodium carbonate solution. The methylene chloride solution is dried and concentrated in vacuo, and after distillation of the oil obtained in this way (105 ° C., 5 × 10-3 mm), an oil of 2-amino-3,4,5-trimethoxymethyl benzoate is obtained. b) 6,7,8-TrFrnethoxShiruzolin-4(3H)-on Eine Lösung von 24,2 g 2-Amino-3,4,5-Trimethoxy- methylbenzoat in 80 ml 99%igem Formamid wird 1,25 Stunden zum kückfluss erhitzt. Man kühlt das Reaktionsgemisch ab, versetzt es mit 200 ml Eiswasser, filtriert den Feststoff ab, wäscht mit Wasser und trocknet, wobei man zum 6,7,8-Trimethoxychinazolin-4(3H)on vom Smp. 2202220C gelangt. b) 6,7,8-TrFrnethoxShiruzolin-4 (3H) -one A solution of 24.2 g of 2-amino-3,4,5-trimethoxymethylbenzoate in 80 ml of 99% formamide is refluxed for 1.25 hours. The reaction mixture is cooled, 200 ml of ice water are added, the solid is filtered off, washed with water and dried, giving 6,7,8-trimethoxyquinazolin-4 (3H) one with a melting point of 2202220C. PATENTA0NSPRUCH Verfahren zur Herstellung von 6,7,8-Trialkoxychin azolin-4(3H)onen der Formel I, EMI1.4 worin Y, Y1 und Y2 gleich oder verschieden sein können und jeweils Alkoxy mit 1-3 Kohlenstoffatomen bedeuten, dadurch gekennzeichnet, dass man Verbindungen der Formel II, EMI1.5 worin Y, Y1 und Y obige Bedeutung besitzen, mit Formamid kondensiert. PATENT CLAIM Process for the preparation of 6,7,8-trialkoxyquin azolin-4 (3H) ones of the formula I, EMI1.4 in which Y, Y1 and Y2 can be identical or different and are each alkoxy with 1-3 carbon atoms, characterized in that compounds of the formula II, EMI1.5 wherein Y, Y1 and Y have the above meanings, condensed with formamide.
CH1519573A 1969-12-05 1970-11-23 4-amino-6,7,8-trimethoxyquinazolines CH545296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87043969A 1969-12-05 1969-12-05

Publications (1)

Publication Number Publication Date
CH545296A true CH545296A (en) 1974-01-31

Family

ID=25355372

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1519273A CH554878A (en) 1969-12-05 1970-11-23 Process for the preparation of 6,7,8-TRIALCOXYCHINAZOLINES SUBSTITUTED IN POSITION 4.
CH1519573A CH545296A (en) 1969-12-05 1970-11-23 4-amino-6,7,8-trimethoxyquinazolines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1519273A CH554878A (en) 1969-12-05 1970-11-23 Process for the preparation of 6,7,8-TRIALCOXYCHINAZOLINES SUBSTITUTED IN POSITION 4.

Country Status (8)

Country Link
AT (1) AT317218B (en)
CH (2) CH554878A (en)
DK (2) DK126329B (en)
NO (1) NO130477C (en)
PL (1) PL77821B1 (en)
RO (1) RO60107A (en)
SU (1) SU400098A3 (en)
ZA (1) ZA708200B (en)

Also Published As

Publication number Publication date
NO130477C (en) 1974-12-18
DK126329B (en) 1973-07-02
ZA708200B (en) 1972-07-26
PL77821B1 (en) 1975-04-30
SU400098A3 (en) 1973-10-03
AT317218B (en) 1974-08-26
CH554878A (en) 1974-10-15
NO130477B (en) 1974-09-09
RO60107A (en) 1976-08-15
DK125799B (en) 1973-05-07

Similar Documents

Publication Publication Date Title
EP0070397B1 (en) Process and catalyst for the preparation of cyclic imines
CH545296A (en) 4-amino-6,7,8-trimethoxyquinazolines
DE2329545C2 (en) 1,2-bis-oxazolinyl- (2) -cyclobutanes and processes for their preparation
DE1052983B (en) Process for the production of cyclohexanone
DE1277244B (en) Process for the preparation of 2,3-dibromobutene- (2) -diol- (1,4), 2,2,3,3-tetrabromobutanediol- (1,4) and / or mucobromic acid
AT352097B (en) PROCESS FOR THE PRODUCTION OF CYANIUM FORMAMIDE FROM HYDROGEN CYANE AND OXYGEN
DE819692C (en) Process for the preparation of 4-amino-2,6-dialkyl- or -diaralkylpyrimidines
DE2161995C3 (en) Process for the preparation of benzotrifluoride or its derivatives
AT288363B (en) Process for the preparation of new β-aroyl-β-haloacrylic acids
CH551982A (en) 4-amino-6,7,8-trimethoxyquinazolines
DE1168413B (en) Process for the preparation of monomethyl ester monoamides of carbocyclic, aromatic dicarboxylic acids
AT375343B (en) METHOD FOR PRODUCING THE NEW 1-METHYL-5 (P-TOLUOYL) -3-CARBOXYPYRROL-2-ACETIC ACID
DE2139084B2 (en) Process for the preparation of 4,4-diphenyl-piperidines
AT272332B (en) Process for the production of coumarin
AT211322B (en) Process for the preparation of substituted tetrahydro-oxazines
DE1445895C (en) Process for the preparation of 2 dehydroemetine derivatives
AT233018B (en) Process for the preparation of new iminodibenzyl derivatives
DE823292C (en) Process for the partial hydrogenation of unsaturated organic compounds
DE3429439A1 (en) METHOD FOR PRODUCING PANTOLACTONE
AT226238B (en) Process for the production of ω-ureidocarboxylic acids
AT273967B (en) Process for the preparation of new salts of substituted s-triazines
AT247339B (en) Process for the production of new quinazolone compounds
AT200572B (en) Process for the production of aromatic di- and polycarboxylic acids
DE949652C (en) Process for the rearrangement of naphthalic acid into naphthalene-2,6-dicarboxylic acid
AT225173B (en) Process for the preparation of α, β- δ, ε-unsaturated carboxylic acid esters

Legal Events

Date Code Title Description
PL Patent ceased